Keckley Report December 11, 2017
Paul Keckley Ph.D.

Coverage about the Aetna acquisition by CVS has been pervasive since last Monday’s announcement. The headlines in national, local and trade industry outlets reflect the balance of intrigue and skepticism that’s greeted the deal (see Fact File). Here’s what we know for sure:

It’s an acquisition by CVS. CVS is the buyer; Aetna is the seller. For the past few years, Aetna CEO Mark Bertolini had told analysts that the company was transforming itself from insurance to a multi-faceted strategy focused on analytics and partnerships with providers. He iterated the company’s acquisitions of Active Health, Medicity and several IT related entities and its partnerships with major health systems like Inova, Texas Health and others to illustrate the new focus. Meanwhile,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health System / Hospital, Medicaid, Medicare, Mergers & Acquisitions / JV, Payer, Physician, Primary care, Retail care, Urgent care
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article